Chronic Phase Chronic Myeloid Leukemia, BCR-ABL1 Positive

Chronic Phase Chronic Myeloid Leukemia, BCR-ABL1 Positive — Trials · CancerIndex

Clinical trials

Registered studies

122 studies whose conditions map to this entity or one of its descendants. Status and phase are as posted on ClinicalTrials.gov. 50 studies per page.

Active: 28
Recruiting: 13
Ph III recruiting: 2
Growth YoY: —
Industry share: 32%
Top sponsor: City of Hope Medical Center
Termination share: 33.3%

Computedformula ci-trial-intel-v1 · interventional studies · entity + NCIt descendants · hover a figure for its formulaCompare cancers Terminated studies (16)

clinicaltrialsPublishedShowing 1–3 of 3 studies matching the filters · status and phase as posted by the registrant; each row links to the study record.

NCT	Title	Status	Phase	Enrollment (n)	Sponsor	Countries	Last update	Source
NCT06423911	Study of Olverembatinib (HQP1351) in Patients With CML-CP(POLARIS-2)	recruiting	Phase 3	333	Ascentage Pharma Group Inc.INDUSTRY	16	Sep 15, 2026	clinicaltrials
NCT03459534	A Phase 3 Study for the Efficacy and Safety of Radotinib in CP-CML Patients With Failure or Intolerance to Previous TKIs	recruiting	Phase 3	173	Il-Yang Pharm. Co., Ltd.INDUSTRY	4	Sep 3, 2026	clinicaltrials